Bivalirudin 70436-0025

Product NDC

70436-0025

Manufacturer: Slate Run Pharmaceuticals, Llc
Dosage Form: Injection, Powder, Lyophilized, For Suspension
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 30, 2021
Listing Expires: December 31, 2026
Application: ANDA213078

Need to source Bivalirudin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bivalirudin	250 mg/1

Drug Class

Anti-coagulant [EPC]Direct Thrombin Inhibitor [EPC]Anti-coagulant [EPC]

Packaging Options(2)

70436-0025-80

1 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL, SINGLE-DOSE (70436-025-80)

View →

70436-0025-82

10 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTON (70436-025-82)

View →